Bariatrics and Vitamin B12 Injections
Customize your policy alerts
Sign up for Blue KC Policy POL-PP-220 alerts
Get alerted when Policy POL-PP-220 changes without checking for updates manually.
Monitor payer policy activity
Defines coverage and reimbursement rules for Vitamin B12 testing and injections relating to bariatric patients and general screening, and specifies billing rules during the global surgical period. Affects professional and facility providers and multiple Blue KC lines of business.
No material clinical or coverage changes in this revision.
Coverage Criteria and Billing Rules
Coverage criteria and billing rules
Covered, non‑covered, and billing rules for Vitamin B12 screening, diagnostic testing, and injections — applied as written below.
Repeat testing interval: no sooner than 3 months after therapy initiation.
Bariatric-specific allowance
- Screening and injections for Vitamin B12 deficiency may be allowed for patients who have undergone bariatric procedures (e.g., Roux-en-Y gastric bypass, sleeve gastrectomy, biliopancreatic diversion/duodenal switch) when performed outside of the global period.
Relevant Codes and Testing Intervals
| 82607 | Cyanocobalamin (Vitamin B-12) |
| 82608 | Cyanocobalamin (Vitamin B-12); unsaturated binding capacity |
| 83921 | Organic acid, single, quantitative |
| 83090 | Homocysteine |
| J3425 | Injection, hydroxocobalamin, IM, 10 mcg |
| J3420 | Injection, vitamin B-12 cyanocobalamin, up to 1,000 mcg |
| 96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular |
Billing Considerations and Prior Authorization
Prior Authorization / Billing Considerations
Prior authorization is required when applicable by member benefit; verify coverage and obtain prior authorization before providing services not explicitly covered. B12 injections include time for pre-service evaluation. Submit an E/M (99202-99215) only when the E/M service is significant, separately identifiable, and clearly exceeds the pre-service evaluation inherent to the injection.
- Affected codes: J3420 (Vitamin B12, cyanocobalamin, per 1,000 mcg) — injected product
- Affected codes: 96372 (Therapeutic, prophylactic, or diagnostic injection) — administration
- Affected codes: 99202-99215 (Office/outpatient E/M) — bill only if significant, separately identifiable service beyond pre-service evaluation
- Note: Confirm whether member benefits require prior authorization for B12 laboratory testing or injections
- Billing rule: Do not bill J3420 and 96372 separately during the 90-day global period following bariatric surgery (e.g., Roux-en-Y, gastric bypass, sleeve gastrectomy, biliopancreatic diversion/duodenal switch)
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.